CambridgeIP
Key Directions of Innovation in the Drug Delivery Devices Space

 July 2010

CIP Univ Logo gif
CambridgeIP is a leading provider of technology business intelligence and IP-based strategy services to the technology community, capital firms, and policy makers. 

Contact Quentin Tannock
Chairman & Founder
 
N. American Business Development Manager

CambridgeIP is headquarted in Cambridge, UK with representation in Boston, Houston, London and Geneva.

 Contact us today for more information on how we can provide fact-based input for your key business strategy decisions.

Quick Links
UK :: +44 01223 778846
 US:: +1-281-377-4260
Greetings!

Quentin Tannock (Chairman, CambridgeIP) presented at BIO 2010 in Chicago on the topic 'Fact-based Strategy Development: Accelerating your Out-Licensing'. We thought you might like to view Quentin's presentation which includes which includes our thoughts on the key directions of innovation in the inhaler device space, together with examples of our work in auto-injectors and other spaces.

Click here to view our presentation.

To access further research or to discuss our findings, contact our Chairman Quentin Tannock quentin.tannock@cambridgeip.comor our Business Development Manager - North America Mark Meyer mark.meyer@cambridgeip.com

Yours sincerely,

The CambridgeIP Team

Technology Matrix of the Autoinjector Field
Nano-Technology Manufacturing Methods

About CambridgeIP

Please feel free to get in touch with our principals:
Quentin Tannock: quentin.tannock@cambridgeip.com
Ilian Iliev: ilian.iliev@cambridgeip.com

About Us

CambridgeIP is a provider of technology, business intelligence and IP strategy services to the technology community and policy makers.

The company has a proprietary platform enabling efficient handling, real time analysis and online display of large patent (and other structured data) datasets, unique analytics, and highly granular focus at the level of individual technology, inventor or organisation. We provide fact-based IP strategy, R&D and investment due diligence services to the technology community at large.
 
CambridgeIP runs Boliven.com a leading online information portal for R&D and IP professionals making available over 100 million scientific documents.  The company has a proprietary platform enabling efficient handling, real time analysis and online display of large patent (and other structured data) datasets, unique analytics, and highly granular focus at the level of individual technology, inventor or organisation.  We provide fact-based IP strategy, R&D and investment due diligence services to the technology community at large. 

We have representations in Cambridge and London (UK), Houston and Boston (USA) and Geneva (Switzerland)

Mailing Address:
8A Kings Parade
Cambridge
CB2 1SJ 
United Kingdom
Visit www.cambridgeip.com for more details.

Disclaimer

This newsletter includes analysis, together with opinions or financial observations expressed by CambridgeIP. They do not constitute legal advice. The reader should not rely on them to make (or to refrain from making) any decision. Any decision is the reader's sole responsibility.